Adjuvant Properties of Silver and Dimethyl Sulfoxide Nanoparticles in Studying Antibacterial Activity of Antibiotics against E. Coli

Author(s)

Inga Nikolaevna Ryumkina , Nikolay Nikolaevich Shkil , Ekaterina Vladimirovna Nefyodova , Nikolay Alekseevich Shkil , Grigory Antonovich Nozdrin , Marina Viсtorovna Lazareva , Olga Victorovna Rasputina ,

Download Full PDF Pages: 119-126 | Views: 593 | Downloads: 139 | DOI: 10.5281/zenodo.4286955

Volume 4 - October 2020 (10)

Abstract

The research results showed that silver nanoparticles have adjuvant properties that increase the bactericidal performance of antibiotics, more than when mono-use with dimethyl sulfoxide (DMSO) and when they are co-cultured. The bactericidal activity of silver nanoparticles against E. coli (Escherichia coli) ATCC 25922 was 0.08, and the E. coli isolate was 0.32 μg / ml. The study of the bactericidal activity with dimethyl sulfoxide for E. coli ATCC 25922 made it possible to establish it at the level of 9.75, and for the E. coli isolate is 4.86 μg / ml. The reference E. coli strain ATCC 25922 had the highest sensitivity of both AgNPs and their combination with antibiotics in comparison with the E. coli isolate, which was isolated from an animal with clinical manifestation of an infectious disease.
The combination of AgNPs and the antibiotic enrofloxacin, gentamicin, ceftimag, cypromag, oxytetracycline, ampicillin showed the greatest increase in bactericidal activity against both E. coli ATCC 25922 and E. coli isolate than AgNPs + antibiotic + DMSO, except for cloxacillin's in the study with isolate E. coli.

Keywords

Antibiotic, Argovit, Bactericidal Activity, Enrofloxacin, Silver Nanoparticles

References

               i.            World Health Organization, (2001). WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, WHO/CDS/CSR/DRS/2001.2.

      ii.            Sidorenko, S.V., (2004). Molecular basis of antibiotic resistance. Advances in Biological Chemistry, vol. 44, pp. 263-306.

    iii.            Strategy for preventing the spread of antimicrobial resistance: order of the Government of the Russian Federation, no. 2045-p dated September 25, 2017.

     iv.            Yuan, Y.G., et al., (2017). Effects of silver nanoparticles on multiple drug-resistant strains of staphylococcus aureus and pseudomonas aeruginosa from mastitis- infected goats: an alternative approach for antimicrobial therapy. International Journal of Molecular Sciences, vol. 18(3). DOI: 10.3390/ijms18030569.

       v.            Abdelgawad, A.M., et al., (2014). Antimicrobial wound dressing nanofiber mats from multicomponent (chitosan/silver-NPs/polyvinyl alcohol) systems. Carbohydrate Polymers, no.100. DOI: 10.1016/j.carbpol.2012.12.043.

     vi.            Aboelfetoh, E.F., et al., (2017). Eco-friendly synthesis of silver nanoparticles using green algae (Caulepra serrulate). Reaction optimization, catalytic and antibacterial activities. Environmental Monitoring and Assessment, pp. 724-731.DOI: 10.1007/s10661-017-6033-0 

   vii.            Goggin, R., et al., (2014). Colloidal Silver: A Novel Treatment for Staphylococcus Aureus Biofilms? International Forum of Allergy and Rhinology, vol. 4, no. 3, pp. 171-175. DOI:10.1002/alr.21259.

 viii.            Richter, K., et al., (2017).  Taking the Silver Bullet Colloidal Silver Particles for the Topical Treatment of Biofilm-Related Infections. ACS Applied Materials & Interfaces, vol .9, no. 26, pp. 21631-21638, DOI: 10.1021/acsami.7b03672 

     ix.            Barras, F., et al., (2018). Silver and Antibiotic, New Facts to an Old Story. Antibiotics (Basel), vol. 7, no. 3, pp. 79. DOI: 10.3390/antibiotics7030079.

       x.            Petica, S., et al., (2008). Colloidal silver solutions with antimicrobial properties. Materials Science & Engineering B: Advanced Functional Solid-State Materials, no.152, pp. 22–27.

     xi.            Lok, C.N., et al., (2007). Silver nanoparticles: partial oxidation and antibacterial activities. Journal of Biological Inorganic Chemistry, vol. 12, no. 4, pp. 527-534. DOI: 10.1007/s00775-007-0208-z.

   xii.            Mamonova, I.A., (2013). The influence of nanoparticles of the transition group of metals on antibiotic-resistant strains of microorganisms: Author. dis. ... Cand. Biol. Sciences, p. 21.

 xiii.            Shrivastava, S., et al., (2007). Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology, vol. 18, pp. 225103-225112. DOI: 10.1088/09574484/18/22/225103.

 xiv.            Jung, W.K., et al., (2008). Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Applied & Environmental Microbiology, no. 74, pp. 2171-2178.

   xv.            Morones, J.R., et al., (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, vol. 16, pp. 2346-2353.

 xvi.            Yang, W.J., et al. (2009). Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology, vol. 20, pp. 085-102.

xvii.            Burda, C., et al., (2005). Chemistry and properties of nanocrystals of different shapes. Journal of Chemical Reviews, vol. 105(4), pp. 1025-1102

xviii.            Panacek A., et al., (2006). Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. Journal of Physical Chemistry B., vol. 110 (33), pp. 16248 – 16253.

 xix.            Singh, M., et al., (2013). Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen. Bioprocess and Biosystems Engineering, vol. 36, no. 4, pp. 407-415.

   xx.            Panpaliya, N.P., et al., (2019). In vitro evaluation of antimicrobial property of silver nanoparticles and chlorhexidine against five different oral pathogenic bacteria. Saudi Dental Journal, vol. 31 (1), pp.76-83. DOI: 10.1016/j.sdentj.2018.10.004.

Cite this Article: